Euclises Pharmaceuticals
Latest round
- Series A
Last raised
- Aug 2017
Total raised
- $2.6M
Investors
- 8
About Euclises Pharmaceuticals
Based in Missouri, US, Euclises Pharmaceuticals operates as a clinical-stage biopharmaceutical company that develops oral, small-molecule drugs that target COX-2 to disrupt the tumor microenvironment and kill cancer cells. The company was Co-founded by John Talley and others. Louis Arch Angels, and BioGenerator. Sandage, Jr. The company develops oral, small-molecule drugs that target COX-2 to disrupt the tumor microenvironment and kill cancer cells. When combined with immune checkpoint inhibitors by eliminating COX-2/PGE-2 mediated tumor immune evasion, the molecule shows monotherapy to slow tumor growth and completely regress tumors.
Who invested in Euclises Pharmaceuticals
8 investors across 3 rounds
See all investors in Euclises Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Euclises Pharmaceuticals
Who invested in Euclises Pharmaceuticals?
Euclises Pharmaceuticals has 8 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Euclises Pharmaceuticals raised?
Euclises Pharmaceuticals has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Euclises Pharmaceuticals last raise money?
Euclises Pharmaceuticals's most recent round on record is a Series A, in Aug 2017.
What does Euclises Pharmaceuticals do?
Based in Missouri, US, Euclises Pharmaceuticals operates as a clinical-stage biopharmaceutical company that develops oral, small-molecule drugs that target COX-2 to disrupt the tumor microenvironment and kill cancer cells.
Where is Euclises Pharmaceuticals headquartered?
Euclises Pharmaceuticals is headquartered in St. Louis, US.
Which VCs invest in companies like Euclises Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Euclises Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Euclises Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.